MRP cut-off value | Hepatitis | Non-hepatitis | Sensitivity | Specificity | PPV | NPV | |
---|---|---|---|---|---|---|---|
Totala (N = 199) | > 10.44 | 71 | 39 | 71.72% | 61.00% | 64.55% | 68.54% |
≤10.44 | 28 | 61 | |||||
Training Set (N = 105) | > 10.44 | 40 | 20 | 72.73% | 60.00% | 66.67% | 66.67% |
≤10.44 | 15 | 30 | |||||
Validation Set (N = 94) | > 10.44 | 31 | 19 | 70.45% | 62.00% | 62.00% | 70.45% |
≤10.44 | 13 | 31 | |||||
Pneumonia pediatric patients without MP infection (N = 175) | > 10.44 | 55 | 59 | 64.70% | 34.44% | 48.25% | 50.82% |
≤10.44 | 30 | 31 |